Upsher-Smith Laboratories Competitors and Similar CompaniesClear all

Upsher-Smith Laboratories's competitors and similar companies include Aptuit, Cristcot and LQT Therapeutics.
Upsher-Smith Laboratories
Upsher-Smith Laboratories
Upsher-Smith Laboratories is a pharmaceutical company providing generic and branded medications.
Aptuit
Aptuit
Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions.
Cristcot
Cristcot
Cristcot is a life sciences company focused on drug delivery systems, combination products, and specialty drug formulations.
LQT Therapeutics
LQT Therapeutics
LQT Therapeutics is a life-science company that develops a series of preclinical compounds to provide a treatment option for patients with Long QT Syndrome (“LQTS”) and other cardiac arrhythmias.
Founding Date
Founding Date
1919
Founding Date
1993
Founding Date
2008
Founding Date
2019
Type
Type
Subsidiary
Type
Subsidiary
Type
Private
Type
Private
Tags
Locations
Locations
Maple Grove, US HQ
Denver, US
Morristown, US
Plymouth, US
Locations
Greenwich, US HQ
Verona, IT
Reinach, CH
Milton, GB
Locations
Concord, US HQ
Concord, US
Locations
Laval, CA HQ
Employees
Employees
439
Employees
761
Employees
1427% increase
Employees
26

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 3m (almost 8 years ago)
Latest funding round
$ 1.4m (over 6 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 3m
Total funding raised
$ 1.4m
For sources of this data, please see the company profile

View Company Profiles

Aptuit
HQ
Greenwich, US

Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions.

View company
Cristcot
HQ
Concord, US
Employees
14↑ 27% increase

Cristcot is a life sciences company focused on drug delivery systems, combination products, and specialty drug formulations.

View company
LQT Therapeutics
HQ
Laval, CA
Employees
26

LQT Therapeutics is a life-science company that develops a series of preclinical compounds to provide a treatment option for patients with Long QT Syndrome (“LQTS”) and other cardiac arrhythmias.

View company